Similar Items: 26 | Validation of a new multi-target antioxidant treatment for the therapy of Duchenne muscular dystrophy
- 29 | RNA-based combinatorial multi-target therapy for the treatment of Duchenne muscular dystrophy
- 16 | Immunoproteasome inhibition positively impacts the gut-muscle axis in Duchenne muscular dystrophy
- Duchenne muscular dystrophy : mutation profiling in view of the emerging gene-based therapies
- Direct AMPK Activation Confers Mutation‐Independent Therapeutic Benefit in Duchenne Muscular Dystrophy
- Duchenne muscular dystrophy in South Africa : molecular aspects
- Gene Editing for Duchenne Muscular Dystrophy: From Experimental Models to Emerging Therapies